Product Security Assessment

Is your vulnerability program built to scale?

AI-accelerated discovery is flooding OEM security backlogs. Our experts will assess how your current program can scale and where Immutaverse can close gaps. $449.

Get an assessment

The bottleneck isn't finding vulnerabilities. It's closing them.

Our team of product security experts will review your current program, identify risks, and propose prioritized next steps for closing gaps

Vulnerability AI models like Claude Mythos have discovered thousands of zero-day vulnerabilities across every major OS and browser, which has created a massive remediation capacity problem.

Most OEM security programs were designed for a fraction of the critical vulnerabilities AI is finding with human-paced triage and sequential patch cycles. They weren’t designed for the volume Mythos and other models are discovering.

The question isn't whether your backlog will grow.

It's whether your program can scale to handle it.

Compliance now requires operational resilience

The pace of vulnerability disclosure isn't the only pressure your program is facing. EU CRA, EU RED, and the US Cyber Trust Mark all require demonstrable, ongoing vulnerability management, not just a policy on paper. The OEMs that treat VulnOps as core infrastructure will be better positioned on both fronts.

Waiting to take action carries real cost: the administrative fines for EU CRA non-compliance run up to €15M or 2.5% of global annual revenue, along with the business risk from a fast-growing backlog that outpaces remediation capacity.

What the assessment covers

Step 1: Complete the questionnaire

Tell us about your current vulnerability management workflows, triage process, tooling, and product portfolio. Takes about 10 minutes.

Step 2: We identify where your program bottlenecks or breaks

Our product security experts review your responses and map your current state against the volume and speed demands of AI-accelerated vulnerability disclosure, identifying where workflows, tooling gaps, and triage bottlenecks can exacerbate risk.

Step 3: Prioritized readout within 2–3 business days

We meet with your team to walk through findings, rank gaps by urgency, and show you how Immutaverse would accelerate reducing risk across your device portfolio.